Roche Nominates New Chairman

Article

Roche nominates Christoph Franz, currently CEO of the Lufthansa Group, to succeed current Roche chairman Franz B. Hummer.

Roche has nominated Christoph Franz, currently CEO of the Lufthansa Group, to succeed current Roche chairman Franz B. Humer in that role. Roche's board of directors will take up the election of Franz at the company's next annual shareholders meeting on March 4, 2014. Humer announced in March 2013 that he would not be seeking re-election as Roche chairman. Franz will not renew his contract as CEO of the Lufthansa Group, which expires on May 31, 2014, in consideration of Roche's top job.

Source: Roche

Recent Videos
Roger Viney from ICE Pharma discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry.
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Related Content